Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/22
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 09/14/16
End: 06/30/19
Due: 06/30/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH | NCT03970031 | Cirius Therapeutics, Inc. | user2@example.com | None | 2022-06-30 | 2024-09-30 | 2025-09-30 | - | - | 2025-07-14 |
| A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH | NCT02784444 | Cirius Therapeutics, Inc. | user2@example.com | None | 2016-09-14 | 2019-06-30 | 2020-06-30 | - | - | 2025-07-14 |